Denis Boyle

Title: Denis Boyle - Innovator in Pharmaceutical Composition

Introduction

Denis Boyle is a notable inventor based in Hermann, MO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of genetic disorders. His work focuses on innovative solutions that address critical health issues.

Latest Patents

Denis Boyle holds a patent for a pharmaceutical composition comprising a frataxin fusion protein. This patent, titled "Pharmaceutical composition comprising frataxin fusion protein and methods of use thereof," outlines the use of a TAT-FXN fusion polypeptide. The methods described in the patent aim to treat subjects diagnosed with Friedrich's Ataxia and/or hypertrophic cardiomyopathy. This innovative approach has the potential to improve the quality of life for individuals affected by these conditions.

Career Highlights

Denis Boyle is currently associated with Larimar Therapeutics, Inc., where he continues to advance his research and development efforts. His work at the company reflects his commitment to finding effective treatments for challenging medical conditions. With a focus on innovative pharmaceutical solutions, he has established himself as a key player in the industry.

Collaborations

Denis Boyle collaborates with Thomas Ransohoff, leveraging their combined expertise to enhance the development of therapeutic solutions. Their partnership exemplifies the importance of teamwork in the field of pharmaceutical innovation.

Conclusion

Denis Boyle's contributions to pharmaceutical compositions and his dedication to addressing serious health issues make him a significant figure in the field. His innovative work continues to pave the way for advancements in treatment options for genetic disorders.